BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ)
$54.55 -1.75 (-3.1083%)
Analysed BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ) News Sources
2 Profitable Stocks with Promising Prospects and 1 Facing Challenges
08-04-2026
yahoo.com
Hims & Hers Health, Regeneron, Biogen, BioMarin Pharmaceutical, and Moderna Shares Are Falling, What You Need To Know
03-04-2026
yahoo.com
Here is Why BioMarin (BMRN) is Projected to Rally
31-03-2026
yahoo.com
BioMarin Pharmaceutical Inc. (BMRN) Rated Overweight at Wells Fargo Despite Voxzogo Phase 2 Study Discontinuations
30-03-2026
yahoo.com
Exploring High Growth Tech Stocks In The US Market March 2026
27-03-2026
yahoo.com
1 of Wall Street’s Favorite Stock with Promising Prospects and 2 We Find Risky
26-03-2026
yahoo.com
BioMarin (BMRN) Down 13.6% Since Last Earnings Report: Can It Rebound?
25-03-2026
yahoo.com
Q4 Earnings Highlights: BioMarin Pharmaceutical (NASDAQ:BMRN) Vs The Rest Of The Therapeutics Stocks
20-03-2026
yahoo.com
Biotech Stock Up 372% Gets Sold as New Pick Rises 40% in 2026
20-03-2026
fool.com
This Biotech Stock Has Surged 250% in a Year as One Investor Discloses $10 Million New Position
20-03-2026
fool.com
What is the current price of BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ)?
The current price of BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ) is $54.55.
BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ) absolute price change since previous trading day?
The absolute price change of BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ) since the previous trading day is $-1.75.
BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ) percentage price change since previous trading day?
The percentage price change of BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ) since the previous trading day is -3.1083%.
What is the most recent average sentiment score for BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ)?
The most recent average sentiment score for BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ) is 68 out of 100.
What is the most recent average sentiment for BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ)?
The most recent sentiment for BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ) is .
SEC-8K** Filing Available For BIOMARIN PHARMACEUTICAL INC (BMRN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.